Office for State, Tribal, Local and Territorial Support (OSTLTS); Meeting and Tribal Consultation Session, 75106-75107 [2015-30357]

Download as PDF 75106 Federal Register / Vol. 80, No. 230 / Tuesday, December 1, 2015 / Notices tkelley on DSK3SPTVN1PROD with NOTICES uses permitted by the Privacy Act, in the Commission’s privacy policy, at https://www.ftc.gov/ftc/privacy.htm. Analysis of Proposed Consent Order To Aid Public Comment The Federal Trade Commission (‘‘FTC’’) has accepted, subject to final approval, an agreement containing a consent order from Progressive Chevrolet Company and Progressive Motors, Inc. The proposed consent order has been placed on the public record for thirty (30) days for receipt of comments by interested persons. Comments received during this period will become part of the public record. After thirty (30) days, the FTC will again review the agreement and the comments received, and will decide whether it should withdraw from the agreement and take appropriate action or make final the agreement’s proposed order. The respondents are motor vehicle dealers. According to the FTC complaint, respondents advertised that consumers could lease the advertised vehicles at the monthly payment amounts prominently stated in their advertisements. The complaint alleges that respondents violated Section 5(a) of the Federal Trade Commission Act, 15 U.S.C. 45(a), because they failed to disclose, and/or failed to disclose adequately, that the offer requires a minimum credit score that is greater than the credit score of the majority of consumers. This information would be material to consumers in deciding whether to visit respondents’ dealerships and/or whether to lease an automobile from respondents. The complaint also alleges that respondents’ leasing advertisements violated the Consumer Leasing Act (CLA) and Regulation M by failing to disclose or to disclose clearly and conspicuously required terms. Specifically, respondents’ advertisements prominently stated the monthly payment amounts for a vehicle lease— a triggering term under the CLA—but failed to disclose, or inconspicuously disclosed at the bottom of the ad in much smaller type, the required information set forth by the CLA. The proposed order is designed to prevent the respondents from engaging in similar deceptive practices in the future. • Part I.A. addresses the Section 5 allegation by prohibiting respondents from advertising the amount of any monthly payment, periodic payment, initial payment, or down payment, or the length of payment term, unless the representation is non-misleading, and respondents clearly and conspicuously disclose all qualifications or restrictions on the consumer’s ability to obtain the VerDate Sep<11>2014 23:35 Nov 30, 2015 Jkt 238001 represented terms, including qualifications or restrictions based on the consumer’s credit score. Additionally, if a majority of consumers likely will not be able to meet a credit score qualification or restriction stated in the advertisement, respondents must clearly and conspicuously disclose that fact. • Part I.B.1. provides that the respondents shall not misrepresent the cost of financing the purchase of an automobile, including by misrepresenting the amount or percentage of the down payment, the number of payments or period of repayment, the amount of any payment, and the repayment obligation over the full term of the loan, including any balloon payment. • Part I.B.2. provides that the respondents shall not misrepresent the cost of leasing an automobile, including by misrepresenting the total amount due at lease inception, the down payment, amount down, acquisition fee, capitalized cost reduction, any other amount required to be paid at lease inception, and the amounts of all monthly or other periodic payments. • Part I.C. provides that the respondents shall not misrepresent any other material fact about the price, sale, financing, or leasing of any automobile. • Part II of the order addresses the CLA and Regulation M allegations by prohibiting lease advertisements that: A. State the amount of any payment or that any or no initial payment is required at lease inception, without disclosing clearly and conspicuously the following terms: Æ That the transaction advertised is a lease; Æ The total amount due prior to or at consummation or by delivery, if delivery occurs after consummation; Æ the number, amounts, and timing of scheduled payments; Æ whether or not a security deposit is required; and Æ that an extra charge may be imposed at the end of the lease term where the consumer’s liability (if any) is based on the difference between the residual value of the leased property and its realized value at the end of the lease term. B. Fail to comply in any respect with Regulation M, 12 CFR part 213, as amended, and the Consumer Leasing Act, 15 U.S.C. 1667–1667f, as amended. • Part III requires respondents to keep copies of relevant advertisements and materials containing representations. • Part IV requires that respondents provide copies of the order to certain of their personnel. PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 • Part V requires notification to the Commission regarding changes in corporate structure that might affect compliance obligations under the order. Part VI requires the respondents to file compliance reports with the Commission. Finally, Part VII is a provision ‘‘sunsetting’’ the order after twenty (20) years, with certain exceptions. The purpose of this analysis is to aid public comment on the proposed order. It is not intended to constitute an official interpretation of the complaint or proposed order, or to modify in any way the proposed order’s terms. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2015–30358 Filed 11–30–15; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Office for State, Tribal, Local and Territorial Support (OSTLTS); Meeting and Tribal Consultation Session In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session: Name: Tribal Advisory Committee (TAC) Meeting and 14th Biannual Tribal Consultation Session. Times and Dates 8:00 a.m.–5:00 p.m., February 9, 2016 (TAC Meeting) 8:00 a.m.–5:00 p.m., February 10, 2016 (TAC Meeting & 14th Biannual Tribal Consultation Session) Place: The TAC Meeting and Tribal Consultation Session will be held at CDC Headquarters, 1600 Clifton Road NE., Global Communications Center, Auditorium B3, Atlanta, Georgia 30329– 4027. Status: The meetings are being hosted by CDC/ATSDR in-person only and are open to the public. Attendees must preregister for the event by Wednesday, January 6, 2016, at the following link: https://www.cdc.gov/tribal/ meetings.html. Purpose: The purpose of these recurring meetings is to advance CDC/ E:\FR\FM\01DEN1.SGM 01DEN1 tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 230 / Tuesday, December 1, 2015 / Notices ATSDR support for and collaboration with tribes, and to improve the health of tribes by pursuing goals that include assisting in eliminating the health disparities faced by Indian Tribes; ensuring that access to critical health and human services and public health services is maximized to advance or enhance the social, physical, and economic status of American Indian/ Alaska Native (AI/AN) people; and promoting health equity for all AI/AN people and communities. To advance these goals, CDC/ATSDR conducts government-to-government consultations with elected tribal officials or their authorized representatives. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. Matters for Discussion: The TAC and CDC leaders’ discussions will include the following public health topics: Adverse childhood experiences, ecigarettes, motor vehicle-related injury prevention, and CDC’s budget. During the 14th Biannual Tribal Consultation Session, tribes and CDC leaders will engage in a listening session with CDC’s director and roundtable discussions with CDC senior leaders. Tribes will also have an opportunity to present testimony about tribal health issues. Tribal leaders are encouraged to submit written testimony by January 8, 2016, to Alleen R. Weathers, Public Health Advisor for the Tribal Support Unit, OSTLTS, via mail to 4770 Buford Highway NE., MS E–70, Atlanta, Georgia, 30341–3717, or email TribalSupport@cdc.gov. Based on the number of tribal leaders giving testimony and the time available, it may be necessary to limit the time for each presenter. The agenda is subject to change as priorities dictate. Information about the TAC, CDC/ ATSDR’s Tribal Consultation Policy, and previous meetings can be found at the following Web link: https://www.cdc. gov/tribal. Contact person for more information: Alleen R. Weathers, Public Health Advisor, CDC/OSTLTS, 4770 Buford Highway NE., MS E–70, Atlanta, Georgia 30341–3717; email: alleen. weathers@cdc.hhs.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the VerDate Sep<11>2014 23:35 Nov 30, 2015 Jkt 238001 Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–30357 Filed 11–30–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1658–NC] RIN 0938–ZB23 Medicare Program; Inpatient Prospective Payment Systems; 0.2 Percent Reduction Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice with comment period. AGENCY: In accordance with the Court’s October 6, 2015 order in Shands Jacksonville Medical Center, Inc., et al. v. Burwell, No. 14–263 (D.D.C.) and consolidated cases that challenge the 0.2 percent reduction in inpatient prospective payment systems (IPPS) rates to account for the estimated $220 million in additional FY 2014 expenditures resulting from the 2midnight policy, this notice discusses the basis for the 0.2 percent reduction and its underlying assumptions and invites comments on the same in order to facilitate our further consideration of the FY 2014 reduction. We will consider and respond to the comments received in response to this notice, and to comments already received on this issue in a final notice to be published by March 18, 2016. DATES: Comment date: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. e.s.t. on February 2, 2016. ADDRESSES: In commenting, refer to file code CMS–1658–NC. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. You may submit comments in one of four ways (please choose only one of the ways listed): 1. Electronically. You may submit electronic comments on this notice to https://www.regulations.gov. Follow the ‘‘Submit a comment’’ instructions. 2. By regular mail. You may mail written comments to the following address ONLY: Centers for Medicare & SUMMARY: PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 75107 Medicaid Services, Department of Health and Human Services, Attention: CMS–1658–NC, P.O. Box 8013, Baltimore, MD 21244–8013. Please allow sufficient time for mailed comments to be received before the close of the comment period. 3. By express or overnight mail. You may send written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–1658–NC, Mail Stop C4–26–05, 7500 Security Boulevard, Baltimore, MD 21244–1850. 4. By hand or courier. Alternatively, you may deliver (by hand or courier) your written comments ONLY to the following addresses: a. For delivery in Washington, DC— Centers for Medicare & Medicaid Services, Department of Health and Human Services, Room 445–G, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. (Because access to the interior of the Hubert H. Humphrey Building is not readily available to persons without Federal government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.) b. For delivery in Baltimore, MD— Centers for Medicare & Medicaid Services, Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244–1850. If you intend to deliver your comments to the Baltimore address, call telephone number (410) 786–9994 in advance to schedule your arrival with one of our staff members. Comments erroneously mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period. For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section. FOR FURTHER INFORMATION CONTACT: IngJye Cheng, (410) 786–2260 or Don Thompson, 410–786–6504. SUPPLEMENTARY INFORMATION: Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have E:\FR\FM\01DEN1.SGM 01DEN1

Agencies

[Federal Register Volume 80, Number 230 (Tuesday, December 1, 2015)]
[Notices]
[Pages 75106-75107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30357]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Office for State, Tribal, Local and Territorial Support (OSTLTS); 
Meeting and Tribal Consultation Session

    In accordance with Presidential Executive Order No. 13175, November 
6, 2000, and the Presidential Memorandum of November 5, 2009, and 
September 23, 2004, Consultation and Coordination with Indian Tribal 
Governments, CDC/Agency for Toxic Substances and Disease Registry 
(ATSDR), announces the following meeting and Tribal Consultation 
Session:
    Name: Tribal Advisory Committee (TAC) Meeting and 14th Biannual 
Tribal Consultation Session.

Times and Dates

8:00 a.m.-5:00 p.m., February 9, 2016 (TAC Meeting)
8:00 a.m.-5:00 p.m., February 10, 2016 (TAC Meeting & 14th Biannual 
Tribal Consultation Session)

    Place: The TAC Meeting and Tribal Consultation Session will be held 
at CDC Headquarters, 1600 Clifton Road NE., Global Communications 
Center, Auditorium B3, Atlanta, Georgia 30329-4027.
    Status: The meetings are being hosted by CDC/ATSDR in-person only 
and are open to the public. Attendees must pre-register for the event 
by Wednesday, January 6, 2016, at the following link: https://www.cdc.gov/tribal/meetings.html.
    Purpose: The purpose of these recurring meetings is to advance CDC/

[[Page 75107]]

ATSDR support for and collaboration with tribes, and to improve the 
health of tribes by pursuing goals that include assisting in 
eliminating the health disparities faced by Indian Tribes; ensuring 
that access to critical health and human services and public health 
services is maximized to advance or enhance the social, physical, and 
economic status of American Indian/Alaska Native (AI/AN) people; and 
promoting health equity for all AI/AN people and communities. To 
advance these goals, CDC/ATSDR conducts government-to-government 
consultations with elected tribal officials or their authorized 
representatives. Consultation is an enhanced form of communication that 
emphasizes trust, respect, and shared responsibility. It is an open and 
free exchange of information and opinion among parties that leads to 
mutual understanding and comprehension.
    Matters for Discussion: The TAC and CDC leaders' discussions will 
include the following public health topics: Adverse childhood 
experiences, e-cigarettes, motor vehicle-related injury prevention, and 
CDC's budget.
    During the 14th Biannual Tribal Consultation Session, tribes and 
CDC leaders will engage in a listening session with CDC's director and 
roundtable discussions with CDC senior leaders. Tribes will also have 
an opportunity to present testimony about tribal health issues.
    Tribal leaders are encouraged to submit written testimony by 
January 8, 2016, to Alleen R. Weathers, Public Health Advisor for the 
Tribal Support Unit, OSTLTS, via mail to 4770 Buford Highway NE., MS E-
70, Atlanta, Georgia, 30341-3717, or email TribalSupport@cdc.gov.
    Based on the number of tribal leaders giving testimony and the time 
available, it may be necessary to limit the time for each presenter.
    The agenda is subject to change as priorities dictate.
    Information about the TAC, CDC/ATSDR's Tribal Consultation Policy, 
and previous meetings can be found at the following Web link: https://www.cdc.gov/tribal.
    Contact person for more information: Alleen R. Weathers, Public 
Health Advisor, CDC/OSTLTS, 4770 Buford Highway NE., MS E-70, Atlanta, 
Georgia 30341-3717; email: alleen.weathers@cdc.hhs.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-30357 Filed 11-30-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.